S

Senti Biosciences
D

SNTI

0.93000
USD
0.02
(2.21%)
مغلق
حجم التداول
100
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
28,964,382
المقالات
المزيد

العنوان: Senti Biosciences Inc.

القطاع: Healthcare
الصناعة: Biotechnology
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow, and SENTI-301A for the treatment of hepatocellular carcinoma.